In The News
Critic blames lack of drug choice for dropout rate from B.C.'s opioid substitution programs
Record numbers of people who use opioids entered drug substitution programs in B.C. last year, but only one third stick with treatment for 12 months, according to a report issued by the provincial health officer.
In the Bronx, heroin woes never went away
If the South Bronx were a state it would have the second-highest rate of drug overdose deaths — 34 per 100,000 people — in the country, after West Virginia.
2016 hep-CORE Report: Monitoring European policy responses to viral hepatitis
Thoughts from Mark Korenjak Board Member, European Liver Patients Association and Prof. Jeffrey V. Lazarus, Associated Researcher, ISGlobal, Hospital Clínic, University of Barcelona, WHO Collaborating Centre on HIV and Viral Hepatitis and Editor-in-Chief, Hepatology, Medicine and Policy.
Recommendations for the management of hepatitis C virus infection among people who inject drugs The burden of HCV-related liver disease among people who inject drugs is increasing, but treatment uptake remains extremely low. There are a number of barriers to care which should be considered and systematically addressed, but should not exclude PWID from HCV treatment.
Surge in Glasgow HIV infection rate largest in 30 years New figures show that the number of injecting drug users in the city diagnosed with the virus has risen by 600 per cent in the past year.
Global hepatitis report, 2017 This report describes, for the first time, the global and regional estimates on viral hepatitis in 2015, setting the baseline for tracking progress in implementing the new global strategy.